Skip to Main Content Skip to Site Map Skip to Accessibility Statement

BEAMM-2

November 27, 2025
Trial BEAMM-2
Cancer Type Haematological Cancers and Myeloma
Hospital(s) Belfast City Hospital
Information

A Retrospective Chart Review Study Of Belantamab Mafodotin Combination Therapies Among Patients With Multiple Myeloma From First Relapse